The global infection surveillance solutions market reached a value of USD 702.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,363.9 Million by 2033, exhibiting a growth rate (CAGR) of 7.27% during 2025-2033. The market is experiencing steady growth driven by the increasing prevalence of healthcare-associated infections (HAIs), stringent regulatory requirements, rapid digitization across the healthcare sector, and growing investments in healthcare IT infrastructure.

Key Stats for Infection Surveillance Solutions Market:

• Infection Surveillance Solutions Market Value (2024): USD 702.5 Million
• Infection Surveillance Solutions Market Value (2033): USD 1,363.9 Million
• Infection Surveillance Solutions Market Forecast CAGR: 7.27%
• Leading Segments in Infection Surveillance Solutions Market in 2024: Software (Component), Cloud-based (Deployment Type), Hospitals (End User)
• Key Regions in Infection Surveillance Solutions Market: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
• Top companies in Infection Surveillance Solutions Market: BD (Becton, Dickinson and Company), Baxter International Inc., Premier Inc., Wolters Kluwer N.V., Gojo Industries Inc., VigiLanz Corporation, DEB Group Ltd., Hygreen Inc., and Others

Why is the Infection Surveillance Solutions Market Growing?

The infection surveillance solutions market size is experiencing robust growth as healthcare systems worldwide confront a persistent challenge that costs lives and billions in healthcare spending. Healthcare-associated infections remain one of the most pressing issues facing modern medicine, and the tools to combat them are evolving rapidly.

The numbers tell a sobering story. HAIs affect millions of patients globally each year, extending hospital stays, increasing treatment costs, and contributing to preventable deaths. These infections don't discriminate—they occur across surgical sites, urinary tract systems, bloodstreams, and respiratory pathways. What makes them particularly challenging is that they're often caused by antibiotic-resistant organisms that complicate treatment and recovery. Healthcare facilities are under immense pressure to reduce infection rates, both from regulators and from patients who rightfully expect safe care.

The COVID-19 pandemic fundamentally changed how healthcare systems view infection surveillance. What was already important became absolutely critical. Hospitals and health systems that had robust surveillance infrastructure could respond more effectively, track outbreaks in real-time, and implement targeted interventions. Those without such systems struggled. This experience has permanently elevated the priority of infection surveillance across healthcare leadership, driving investment and adoption.

Regulatory requirements are becoming more stringent across major healthcare markets. Governments and health authorities recognize that systematic surveillance is essential for infection control. In many countries, hospitals now face financial penalties for high HAI rates, while those demonstrating effective infection control may receive incentive payments. This creates powerful economic motivation for healthcare facilities to invest in comprehensive surveillance solutions that can identify problems early and guide prevention efforts.

The shift toward value-based care is amplifying these pressures. Healthcare providers are increasingly being paid based on outcomes rather than volume of services delivered. HAIs directly impact outcomes—extending stays, requiring additional treatments, and sometimes resulting in readmissions. For hospitals operating under value-based contracts, effective infection surveillance isn't optional—it's fundamental to financial viability. The ability to systematically track infections, identify patterns, and implement evidence-based prevention measures directly impacts both patient outcomes and institutional bottom lines.

Digitization of healthcare is creating unprecedented opportunities for infection surveillance. Electronic health records, laboratory information systems, and admission-discharge-transfer systems generate vast amounts of data that surveillance solutions can analyze. Modern systems can automatically flag potential infections based on laboratory results, medication orders, and clinical documentation—eliminating much of the manual chart review that characterized traditional surveillance. This automation not only saves time but also improves detection sensitivity, catching cases that might have been missed through manual processes.

Request Customization: https://www.imarcgroup.com/request?type=report&id=4857&flag=E

AI Impact on the Infection Surveillance Solutions Market:

Artificial intelligence is fundamentally transforming infection surveillance from a primarily retrospective activity into a proactive, predictive discipline. The implications for patient safety and healthcare efficiency are profound, as AI enables capabilities that were simply impossible with traditional surveillance methods.

Predictive analytics powered by AI are enabling risk stratification at unprecedented levels of sophistication. Machine learning algorithms analyze patient characteristics, clinical data, procedural details, and environmental factors to calculate individualized infection risk scores. These predictions allow clinical teams to implement targeted prevention measures for high-risk patients before infections occur. Early studies suggest AI-driven risk prediction can identify patients at elevated risk with accuracy that significantly exceeds traditional risk assessment tools, enabling more efficient allocation of prevention resources.

Automated case detection is reducing the labor intensity of surveillance while improving detection sensitivity. Natural language processing algorithms scan clinical notes, radiology reports, and nursing documentation to identify potential infections based on signs, symptoms, and clinical context. These systems can flag cases within hours of documentation, compared to the days or weeks required for manual chart review. The combination of structured data analysis—laboratory results, vital signs, medication orders—with unstructured text mining creates comprehensive detection capabilities that catch more infections earlier.

Outbreak detection algorithms are identifying clusters of infections that might otherwise go unnoticed until they've spread extensively. AI systems analyze surveillance data in real-time, comparing current infection patterns against historical baselines and using sophisticated statistical methods to detect anomalies. When potential outbreaks are identified, the systems can automatically alert infection prevention teams, facilitating rapid investigation and intervention. This capability is particularly valuable for detecting subtle patterns—like a gradual increase in a specific organism in a particular unit—that might not trigger human concern until the problem has escalated.

Antimicrobial stewardship is benefiting from AI-powered decision support. These systems analyze local antibiotic resistance patterns, patient-specific factors, and evidence-based treatment guidelines to recommend optimal antimicrobial therapy. By helping clinicians select appropriate antibiotics and adjust treatment based on culture results, AI tools support both effective infection treatment and efforts to slow resistance development. Some systems are demonstrating significant improvements in appropriate antibiotic use while reducing unnecessary broad-spectrum therapy.

Leading Players of Infection Surveillance Solutions Market:

According to IMARC Group's latest analysis, prominent companies shaping the global infection surveillance solutions landscape include:

• BD (Becton, Dickinson and Company)
• Baxter International Inc.
• Premier Inc.
• Wolters Kluwer N.V.
• Gojo Industries Inc.
• VigiLanz Corporation
• DEB Group Ltd.
• Hygreen Inc.

These leading providers are expanding their footprint through strategic partnerships, continuous innovation in AI and analytics capabilities, cloud-based platform development, and comprehensive integration with electronic health record systems to meet growing demands for automated, real-time infection surveillance across healthcare facilities globally.

Key Developments in Infection Surveillance Solutions Market:

• Recent Innovation: Healthcare facilities are implementing AI-powered predictive analytics for proactive infection risk management, representing a significant shift from reactive to preventive surveillance. These systems analyze patient data in real-time to identify individuals at elevated risk, enabling targeted prevention interventions before infections develop. Early adopters report significant reductions in HAI rates and improved resource allocation for infection prevention activities.
• Technology Advancement: Automated surveillance systems utilizing natural language processing and machine learning are increasingly deployed across hospital networks, reducing manual surveillance workload by up to 70% while improving detection sensitivity. These platforms can process thousands of patient records daily, identifying potential infections that might be missed through traditional manual review methods.
• Market Expansion: Cloud-based surveillance solutions are experiencing rapid adoption, particularly among smaller healthcare facilities and multi-site healthcare systems. These platforms offer sophisticated capabilities previously accessible only to large academic medical centers, democratizing access to advanced surveillance technology while enabling cross-facility benchmarking and best practice sharing.
• Integration Progress: Major electronic health record vendors are integrating infection surveillance capabilities directly into their platforms, streamlining data flow and reducing the need for separate standalone systems. This integration improves workflow efficiency for infection preventionists and enhances data completeness by automatically capturing relevant clinical information.
• Regulatory Development: Healthcare authorities worldwide are establishing stricter HAI reporting requirements and surveillance standards, driving demand for comprehensive surveillance solutions. Some jurisdictions now mandate real-time reporting of certain infections, requiring healthcare facilities to invest in systems capable of near-instantaneous detection and reporting.
• Research Findings: Studies published in leading medical journals demonstrate that AI-enhanced surveillance systems can predict surgical site infections with accuracy exceeding 80%, enabling preemptive interventions that reduce infection rates by 25-40% in pilot programs. These findings are accelerating institutional adoption and investment in AI-powered surveillance technologies.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=4857&flag=C

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302